• Facebook
WRassman,M.D. BaldingBlog
  • Menu

The use of topical finasteride with minoxidil produces remarkable results in a study on 300 male patients with genetic balding (photos)

Jun 19, 2019/by William Rassman, M.D./0 /Hair Loss Causes

Dr. Rassman’s Comments:  I saw Dr. Insalaco present these findings at a meeting last month in the United Kingdom. About 200 hair restoration surgeons attended the meeting. Her results (combining Finasteride and minoxidil in a drug formulation) was very impressive, reversing hair loss in various parts of the scalp over an 18 month period of time.  Patient compliance was high and what was most interesting was that there were no sexual side effects reported in her 300 test population. I was so enthusiastic about this, that I asked her to write a short article for this blog.  Based upon her work, I will start prescribing it to my patients who request it. For more information on this, please read more info on Topical Finasteride Consultations.

Personal experience with Local Finasteride

Chiara Insalaco, MD, PhD

Plastic and Reconstructive Surgeon

Hair Restoration Specialist

Rome, Italy

Finasteride, a synthetic 4-azasteroid compound, is an antiandrogen which acts by inhibiting 5-alpha reductase. This enzyme converts Testosterone to       Dihydrotestosterone (DHT). It works by partly blocking the body’s production of the male hormone that causes the prostate to enlarge and in those with genetic balding, it is the hormone that induces hair loss.

In December 22nd 1997, the FDA approved finasteride (Propecia®) to treat male pattern hair loss.

Clinical Studies for PROPECIA® (finasteride 1 mg) in the Treatment of Male Pattern Hair Loss shows that 3,8% of men experienced sexual adverse problems:

1.Decreased libido

2.Erectile Disfunction

3.Ejaculation Disorders

In 2011 the U.S. FDA conducted  a post marketing evaluation of reported case of persistent sexual dysfunction after finasteride discontinuation.  Of the 2527 cases, from 1997 to 2011, the FDA identified 59 reported cases of Sexual Disfunction (2.3% of cases) that lasted 3 or more months after Finasteride Discontinuation. FDA has required Merck to revise the Propecia label to disclose the post marketing sexual adverse events.

Shortly after Merck revised its label, THOUSANDS ( perhaps hundreds of thousands) of websites claim that Propecia and Finasteride cause erectile dysfunction and loss of libido; however, the drug has be used by millions of men, so that it was hard to connect the relationship when looking at the FDA 2.3% incidence of sexual side effects figure.

In Italy, in order to overcome the problem we came up with a new topical formulation

The aim was to achieve:

  1. Maximum absorption through the epidermal layer of the scalp
  2. Minimize the systemic absorption

The first study about topical finasteride is Italian and it was made in 1997:  Mazzarella, G., Loconsole, G., Cammisa, G., Mastrolonardo, G. and Vena, G. (1997). Topical finasteride in the treatment of androgenic alopecia. Preliminary evaluations after a 16-month therapy course. Journal of Dermatological Treatment, 8(3), pp.189-192.  The study was a single-blind, placebo-controlled, 16-month trial carried out in 52 patients with Alopecia Areata using a topical 0.005% finasteride solution. The results showed that the clinical outcome, in terms of both hair regrowth and balding areas reduction, seems to be encouraging, and it also showed an absence of either any evidence of percutaneous absorption of finasteride producing local/systemic untoward effects. In 1997 the FDA approved Propecia® to treat AGA so the study was forgotten!

There are few different compound formulations. They are not Over-the-Counter drugs which can be purchased without a prescription. Only few pharmacies in Italy are able to make it.

The most common for used in Italy is the Finasteride Liposomal Gel.? The liposomal vehicle has a high penetration capacity through the epidermis and it’s able to keep the drug locally in the skin for long time.

  • It has a good aesthetic outcome
  • It doesn’t make the hair greasy

This combination has results in good patient compliance

The Milan University evaluated 300 patients treated with the Finasteride Liposomal Gel.

The result: Systemic Absorption is limited to 1/18 compared to the Oral Finasteride dose of 1mg.

In my daily practice I combine both Minoxidil and Finasteride in the same lotion in order to have the maximum result.  Before giving Local Finasteride I always request: (a) DHT (b) Testosterone levels and (c) Sperm Counts. So far none of my patients have shown any changes in these exams or reported any side effects.

There are new scientific studies showing that finasteride doesn’t cause Sexual Side Effects:

These studies suggest that:

  1. Men with Alopecia may be inherently more susceptible to sexual dysfunction regardless of treatment
  2. Sexual dysfunction is not uncommon in the general population regardless of alopecia status

Dr Chiara Insalaco

www.chiarainsalaco.com

https://baldingblog.com/wp-content/uploads/2017/09/logo-small-300x62.png 0 0 William Rassman, M.D. https://baldingblog.com/wp-content/uploads/2017/09/logo-small-300x62.png William Rassman, M.D.2019-06-19 09:00:292019-11-06 15:04:54The use of topical finasteride with minoxidil produces remarkable results in a study on 300 male patients with genetic balding (photos)

You might also like

Can Bulk Analysis Predict Patterns?
Will I Eventually Have My Father's Pattern If I See Some Hair Loss?
Carona Virus projects particles come out of our mouths
Not Hair Loss News - Can You Knock Some Brains Into Yourself?
My colleagues are reporting that they are running out of masks
Hair Loss from Cyst?
Get a virtual consultation with Dr. William Rassman and Dr. Jae Pak for hair loss options. You can learn more by scheduling an appointment.

Reader Comments0

Share this entry
  • Share on Facebook
  • Share on Twitter
  • Share by Mail
Newer Entries Older Entries

Leave a Comment

Want to join the discussion? Feel free to contribute! Note: We do not tolerate offensive language or personal attacks to other readers. Marketing links or commercial advertisements will be deleted.

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

( Will not be published )

+ =

Videos

Podcasts

Ask Dr. Rassman

* Your questions may be published (without your contact information).

Over 21 million women and 35 million men in America suffer from hair loss. For many of these people, the psychological impact on their life is debilitating.

Dr. Rassman is a world leading expert in hair loss with over 25 years of experience and over 50,000 satisfied clients.

About

This site exists to educate about hair loss and hair restoration. Real answers from real physicians… daily.

William R. Rassman, M.D.

Categories

  • ACell (41)
  • African American (145)
  • Age (623)
  • April Fools (3)
  • Density (69)
  • Diseases (545)
  • Drugs (4,035)
  • Drugs (Cause Hair Loss) (535)
  • Favorites (89)
  • Female Hair Loss (1,075)
  • FUE (364)
  • Hair Cloning (178)
  • Hair Loss Causes (7,264)
  • Hair Pieces / Systems (115)
  • Hair Products (1,085)
  • Hair Transplantation (2,059)
  • Hairlines (467)
  • Megasession (15)
  • Other (1,254)
  • Other Surgical Procedures (249)
  • Personal Stories (14)
  • Photos (216)
  • Pigments (128)
  • Podcasts (1)
  • Post-Operative (611)
  • Repair (182)
  • Repost (10)
  • Scalp MicroPigmentation (11)
  • Scarring (346)
  • Thinning (7)
  • Tidbits (34)
  • Training (173)
  • Videos (58)

Archives

  • April 2021 (46)
  • March 2021 (85)
  • February 2021 (70)
  • January 2021 (65)
  • December 2020 (80)
  • November 2020 (76)
  • October 2020 (80)
  • September 2020 (106)
  • August 2020 (96)
  • July 2020 (95)
  • June 2020 (84)
  • May 2020 (83)
  • April 2020 (118)
  • March 2020 (106)
  • February 2020 (96)
  • January 2020 (104)
  • December 2019 (103)
  • November 2019 (71)
  • October 2019 (85)
  • September 2019 (76)
  • August 2019 (68)
  • July 2019 (64)
  • June 2019 (62)
  • May 2019 (59)
  • April 2019 (72)
  • March 2019 (53)
  • February 2019 (61)
  • January 2019 (65)
  • December 2018 (59)
  • November 2018 (42)
  • October 2018 (47)
  • September 2018 (64)
  • August 2018 (68)
  • July 2018 (62)
  • June 2018 (72)
  • May 2018 (68)
  • April 2018 (59)
  • March 2018 (65)
  • February 2018 (44)
  • January 2018 (57)
  • December 2017 (48)
  • November 2017 (37)
  • October 2017 (56)
  • September 2017 (68)
  • August 2017 (79)
  • July 2017 (70)
  • June 2017 (82)
  • May 2017 (98)
  • April 2017 (49)
  • March 2017 (25)
  • February 2017 (42)
  • January 2017 (74)
  • December 2016 (10)
  • November 2016 (3)
  • October 2016 (8)
  • June 2016 (2)
  • May 2016 (1)
  • April 2016 (9)
  • March 2016 (6)
  • February 2016 (4)
  • January 2016 (6)
  • December 2015 (7)
  • November 2015 (9)
  • October 2015 (13)
  • September 2015 (15)
  • August 2015 (24)
  • July 2015 (17)
  • June 2015 (19)
  • May 2015 (21)
  • April 2015 (27)
  • March 2015 (42)
  • February 2015 (41)
  • January 2015 (39)
  • December 2014 (45)
  • November 2014 (45)
  • October 2014 (65)
  • September 2014 (60)
  • August 2014 (62)
  • July 2014 (73)
  • June 2014 (49)
  • May 2014 (59)
  • April 2014 (57)
  • March 2014 (59)
  • February 2014 (60)
  • January 2014 (63)
  • December 2013 (53)
  • November 2013 (55)
  • October 2013 (69)
  • September 2013 (61)
  • August 2013 (66)
  • July 2013 (64)
  • June 2013 (60)
  • May 2013 (67)
  • April 2013 (66)
  • March 2013 (63)
  • February 2013 (59)
  • January 2013 (66)
  • December 2012 (59)
  • November 2012 (74)
  • October 2012 (86)
  • September 2012 (72)
  • August 2012 (88)
  • July 2012 (80)
  • June 2012 (80)
  • May 2012 (83)
  • April 2012 (79)
  • March 2012 (78)
  • February 2012 (80)
  • January 2012 (77)
  • December 2011 (75)
  • November 2011 (75)
  • October 2011 (78)
  • September 2011 (78)
  • August 2011 (92)
  • July 2011 (81)
  • June 2011 (88)
  • May 2011 (86)
  • April 2011 (84)
  • March 2011 (91)
  • February 2011 (68)
  • January 2011 (83)
  • December 2010 (82)
  • November 2010 (82)
  • October 2010 (85)
  • September 2010 (86)
  • August 2010 (88)
  • July 2010 (85)
  • June 2010 (89)
  • May 2010 (87)
  • April 2010 (110)
  • March 2010 (114)
  • February 2010 (99)
  • January 2010 (100)
  • December 2009 (97)
  • November 2009 (96)
  • October 2009 (109)
  • September 2009 (106)
  • August 2009 (105)
  • July 2009 (121)
  • June 2009 (132)
  • May 2009 (120)
  • April 2009 (132)
  • March 2009 (132)
  • February 2009 (136)
  • January 2009 (141)
  • December 2008 (142)
  • November 2008 (128)
  • October 2008 (160)
  • September 2008 (146)
  • August 2008 (148)
  • July 2008 (154)
  • June 2008 (146)
  • May 2008 (149)
  • April 2008 (154)
  • March 2008 (147)
  • February 2008 (148)
  • January 2008 (154)
  • December 2007 (127)
  • November 2007 (142)
  • October 2007 (161)
  • September 2007 (135)
  • August 2007 (160)
  • July 2007 (133)
  • June 2007 (141)
  • May 2007 (173)
  • April 2007 (170)
  • March 2007 (178)
  • February 2007 (161)
  • January 2007 (174)
  • December 2006 (132)
  • November 2006 (162)
  • October 2006 (179)
  • September 2006 (166)
  • August 2006 (188)
  • July 2006 (160)
  • June 2006 (179)
  • May 2006 (186)
  • April 2006 (172)
  • March 2006 (201)
  • February 2006 (175)
  • January 2006 (175)
  • December 2005 (179)
  • November 2005 (103)
  • October 2005 (74)
  • September 2005 (68)
  • August 2005 (79)
  • July 2005 (72)
  • June 2005 (69)
  • May 2005 (72)
  • April 2005 (41)

Links

Disclaimer

This site is intended to educate the public on hair loss topics based on personal experience and opinions from Dr. William Rassman and contributing physician editors. Information provided on BaldingBlog.com should not be used for the purpose of medical diagnosis or treatment.

© Copyright - WRassman,M.D. BaldingBlog - Enfold Theme by Kriesi
  • Facebook
Scroll to top